Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
C. L. Yasuda, A. Al-sabbagh, E. C. Oliveira, B. M. Diaz-Bardales, C. A. A. Garcia & L. M-B Santos. (1999) Interferon β Modulates Experimental Autoimmune Encephalomyelitis by Altering the Pattern of Cytokine Secretion. Immunological Investigations 28:2-3, pages 115-126.
Read now
Read now
Annabelle A. Okada, Hiroshi Keino, Tohru Fukai, Jun-ichi Sakai, Masahiko Usui & Junichiro Mizuguchi. (1998) Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocular Immunology and Inflammation 6:4, pages 215-226.
Read now
Read now
Francine J. Vriesendorp, Robyn E. Fly, Mohammad Khan, Miguel A. Pappolla & Staley A. Brod. (1996) Oral Administration of Type I Interferon Modulates the Course of Experimental Allergic Neuritis. Autoimmunity 24:3, pages 157-165.
Read now
Read now
Jelena Veljić, Dragan Maric & Branislav D. Janković. (1991) Changes of experimental allergic encephalomyelitis by methionine-enkephalin injected into lateral ventricles of the rat brain. International Journal of Neuroscience 59:1-3, pages 81-89.
Read now
Read now
Articles from other publishers (50)
Jin Wang, Kellie Brown, Caroline Danehy, Emmanuel Mérigeon, Stephen Goralski, Samuel Rice, Kwame Torgbe, Fridtjof Thomas, David Block, Henrik Olsen, Scott E. Strome & Elizabeth A. Fitzpatrick. (2023) Fc multimers effectively treat murine models of multiple sclerosis. Frontiers in Immunology 14.
Crossref
Crossref
Maedeh Radandish, Parvin Khalilian & Nafiseh Esmaeil. (2021) The Role of Distinct Subsets of Macrophages in the Pathogenesis of MS and the Impact of Different Therapeutic Agents on These Populations. Frontiers in Immunology 12.
Crossref
Crossref
Insha Zahoor, Bin Rui, Junaid Khan, Indrani Datta & Shailendra Giri. (2021) An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview. Cellular and Molecular Life Sciences 78:7, pages 3181-3203.
Crossref
Crossref
Kelly L. Monaghan & Edwin C.K. Wan. (2020) The Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis. Cells 9:3, pages 611.
Crossref
Crossref
J. Singh, M. Cerghet, L. M. Poisson, I. Datta, K. Labuzek, H. Suhail, R. Rattan & Shailendra Giri. (2018) Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis. Journal of Neuroimmune Pharmacology 14:2, pages 241-250.
Crossref
Crossref
Sneham Tiwari, Jessica Lapierre, Chet Raj Ojha, Kyle Martins, Tiyash Parira, Rajib Kumar Dutta, Allen Caobi, Luis Garbinski, Yasemin Ceyhan, Maria Esteban-Lopez & Nazira El-Hage. (2018) Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis. Journal of Neuroscience Research 96:12, pages 1831-1846.
Crossref
Crossref
Simon Glatigny & Estelle Bettelli. (2018) Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS). Cold Spring Harbor Perspectives in Medicine 8:11, pages a028977.
Crossref
Crossref
Duncheng Wang, Debjani Ghosh, S. M. Touhidul Islam, Cody D. Moorman, Ashton E. Thomason, Daniel S. Wilkinson & Mark D. Mannie. (2016) IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 197:8, pages 2992-3007.
Crossref
Crossref
Trevor Owens, Reza Khorooshi, Agnieszka Wlodarczyk & Nasrin Asgari. (2014) Interferons in the central nervous system: A few instruments play many tunes. Glia 62:3, pages 339-355.
Crossref
Crossref
Daisuke Kudo, Kazuko Uno, Tetsuji Aoyagi, Yukiko Akahori, Keiko Ishii, Emi Kanno, Ryoko Maruyama, Shigeki Kushimoto, Mitsuo Kaku & Kazuyoshi Kawakami. (2013) Low-dose Interferon-α Treatment Improves Survival and Inflammatory Responses in a Mouse Model of Fulminant Acute Respiratory Distress Syndrome. Inflammation 36:4, pages 812-820.
Crossref
Crossref
Dimitrios Karussis. (2013) Immunotherapy of Multiple Sclerosis. BioDrugs 27:2, pages 113-148.
Crossref
Crossref
Robert C. Axtell & Chander Raman. (2012) Janus-like effects of type I interferon in autoimmune diseases. Immunological Reviews 248:1, pages 23-35.
Crossref
Crossref
Cris S Constantinescu, Nasr Farooqi, Kate O'Brien & Bruno Gran. (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology 164:4, pages 1079-1106.
Crossref
Crossref
Nasr Farooqi, Bruno Gran & Cris S. Constantinescu. (2010) Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?. Journal of Neurochemistry 115:4, pages 829-844.
Crossref
Crossref
Saskia L. Smits, Anna de Lang, Judith M. A. van den Brand, Lonneke M. Leijten, Wilfred F. van IJcken, Marinus J. C. Eijkemans, Geert van Amerongen, Thijs Kuiken, Arno C. Andeweg, Albert D. M. E. Osterhaus & Bart L. Haagmans. (2010) Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates. PLoS Pathogens 6:2, pages e1000756.
Crossref
Crossref
Mark D. Mannie, Derek J. Abbott & J. Lori Blanchfield. (2009) Experimental Autoimmune Encephalomyelitis in Lewis rats: IFN-β Acts As a Tolerogenic Adjuvant for Induction of Neuroantigen-Dependent Tolerance. The Journal of Immunology 182:9, pages 5331-5341.
Crossref
Crossref
Alfons Billiau. (2007) Interferons: The pathways of discovery. Journal of Clinical Virology 39:4, pages 241-265.
Crossref
Crossref
Alfons Billiau. (2006) Anti-inflammatory properties of Type I interferons. Antiviral Research 71:2-3, pages 108-116.
Crossref
Crossref
Hubertine Heremans & Alfons Billiau. 2005. Experimental Models of Multiple Sclerosis. Experimental Models of Multiple Sclerosis
313
342
.
Bernd Aufdembrinke, Reinhard Horowski & Joachim‐Friedrich Kapp. 2000. Novel Therapeutic Proteins. Novel Therapeutic Proteins
129
145
.
Lawrence Jacobs, Richard Rudick & Jack Simon. (2000) Extended observations on MS patients treated with IM interferon-β1a (Avonex™): implications for modern MS trials and therapeutics. Journal of Neuroimmunology 107:2, pages 167-173.
Crossref
Crossref
Staley A. Brod, J. William Lindsey & Jerry S. Wolinsky. (2000) Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-?) does not improve experimental autoimmune encephalomyelitis. Annals of Neurology 47:1, pages 127-131.
Crossref
Crossref
Joon H. Uhm, Nora P. Dooley, Olaf Stuve, Gordon S. Francis, Pierre Duquette, Jack P. Antel & Voon Wee Yong. (1999) Migratory behavior of lymphocytes isolated from multiple sclerosis patients: Effects of interferon ?-1b therapy. Annals of Neurology 46:3, pages 319-324.
Crossref
Crossref
W.B Cowden, F.A Cullen, M.A Staykova & D.O Willenborg. (1998) Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. Journal of Neuroimmunology 88:1-2, pages 1-8.
Crossref
Crossref
Peter H van der Meide, Miranda C.D.C de Labie, Sigrid R Ruuls, Reno J Groenestein, Carolien A.D Botman, Tomas Olsson & Christine D Dijkstra. (1998) Discontinuation of treatment with IFN-β leads to exacerbation of experimental autoimmune encephalomyelitis in Lewis rats. Rapid reversal of the antiproliferative activity of IFN-β and excessive expansion of autoreactive T cells as disease promoting mechanisms. Journal of Neuroimmunology 84:1, pages 14-23.
Crossref
Crossref
Nachum Dafny. (1998) Is interferon-α a neuromodulator?. Brain Research Reviews 26:1, pages 1-15.
Crossref
Crossref
Sigrid R Ruuls & Jonathon D Sedgwick. (1998) Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis. Immunology and Cell Biology 76:1, pages 65-73.
Crossref
Crossref
Dimitrios M Karussis & Oded Abramsky. (1998) Immunomodulating therapeutic approaches for multiple sclerosis. Journal of the Neurological Sciences 153:2, pages 239-250.
Crossref
Crossref
Olaf Stuve, Sophie Chabot, Sonia S Jung, Gary Williams & Voon Wee Yong. (1997) Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. Journal of Neuroimmunology 80:1-2, pages 38-46.
Crossref
Crossref
Gillian L Hall, Alastair Compston & Neil J Scolding. (1997) Beta-interferon and multiple sclerosis. Trends in Neurosciences 20:2, pages 63-67.
Crossref
Crossref
Olaf Stüve, Nora P. Dooley, Joon H. Uhm, Jack P. Antel, Gordon S. Francis, Voon Wee Yong & Gary Williams. (2004) Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9. Annals of Neurology 40:6, pages 853-863.
Crossref
Crossref
PATRICIA A. NELSON, YEVGENYA AKSELBAND, SUSAN M. DEARBORN, AHMAD AL-SABBAGH, Z. JANE TIAN, PATRICIA A. GONNELLA, SCOTT S. ZAMVIL, YOUHAI CHEN & HOWARD L. WEINER. (1996) Effect of Oral Beta Interferon on Subsequent Immune Responsiveness. Annals of the New York Academy of Sciences 778:1, pages 145-155.
Crossref
Crossref
Min Yu, Akiko Nishiyama, Bruce D. Trapp & Vincent K. Tuohy. (1996) Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. Journal of Neuroimmunology 64:1, pages 91-100.
Crossref
Crossref
Barry G. W. Arnason, Amit Dayal, Zhi Xiang Qu, Mark A. Jensen, Kursad Gen� & Anthony T. Reder. (1996) Mechanisms of action of interferon-? in multiple sclerosis. Springer Seminars in Immunopathology 18:1, pages 125-148.
Crossref
Crossref
Barry G. W. Arnason, Amit Dayal, Zhi Xiang Qu, Mark A. Jensen, Kursad Genç & Anthony T. Reder. 1996. Immunoneurology. Immunoneurology
243
266
.
STALEY A. BROD, MARGARET SCOTT, DENNIS K. BURNS & J.T. PHILLIPS. (1995) Modification of Acute Experimental Autoimmune Encephalomyelitis in the Lewis Rat by Oral Administration of Type 1 Interferons. Journal of Interferon & Cytokine Research 15:2, pages 115-122.
Crossref
Crossref
Trang T. Duong, Fred D. Finkelman, Bhagirath Singh & Gill H. Strejan. (1994) Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. Journal of Neuroimmunology 53:1, pages 101-107.
Crossref
Crossref
Hillel S. Panitch & Christopher T. BeverJr.Jr.. (1993) Clinical trials of interferons in multiple sclerosis what have we learned?. Journal of Neuroimmunology 46:1-2, pages 155-164.
Crossref
Crossref
Trang T. Duong, Fred D. Finkelman & Gill H. Strejan. (1992) Effect of interferon-γ on myelin basic protein-specific T cell line proliferation in response to antigen-pulsed accessory cells. Cellular Immunology 145:2, pages 311-323.
Crossref
Crossref
T. Nakano, E. Awaki, S. Araga, H. Takai, K. Lnoue, K. Takahashi & Myelitis. (2009) Recurrent herpes zoster myelitis treated with human interferon alpha: a case report. Acta Neurologica Scandinavica 85:5, pages 372-375.
Crossref
Crossref
Trang T. Duong, Joanne St. Louis, Joseph J. Gilbert, Fred D. Finkelman & Gill H. Strejan. (1992) Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. Journal of Neuroimmunology 36:2-3, pages 105-115.
Crossref
Crossref
Lawrence Jacobs & Frederick Munschauer. 1992. Treatment of Multiple Sclerosis. Treatment of Multiple Sclerosis
233
250
.
L. Jacobs, A. M. Salazar, R. Herndon, P. A. Reese, A. Freeman, R. Josefowicz, A. Cuetter, F. Hussain, W. A. Smith, R. Ekes & J. A. O’Malley. 1987. The Biology of the Interferon System 1986. The Biology of the Interferon System 1986
525
529
.
B. D. Jankovi?D. Mari?. (1987) Enkephalins and autoimmunity: Differential effect of methionine-enkephalin on experimental allergic encephalomyelitis in wistar and lewis rats. Journal of Neuroscience Research 18:1, pages 88-94.
Crossref
Crossref
SERGIO L. ABREU, IMMAC THAMPOE & PAUL KAPLAN. (1986) Interferon in Experimental Autoimmune Encephalomyelitis: Intraventricular Administration. Journal of Interferon Research 6:6, pages 627-632.
Crossref
Crossref
Lawrence Jacobs, Robert Herndon, Arnold Freeman, Albert Cuetter, WilliamA. Smith, AndresM. Salazar, PeterA. Reese, Ralph Josefowicz, Farhat Husain, Roslyn Ekes & JudithA. O'Malley. (1986) MULTICENTRE DOUBLE-BLIND STUDY OF EFFECT OF INTRATHECALLY ADMINISTERED NATURAL HUMAN FIBROBLAST INTERFERON ON EXACERBATIONS OF MULTIPLE SCLEROSIS. The Lancet 328:8521-8522, pages 1411-1413.
Crossref
Crossref
F. Hertz & R. Deghenghi. (1985) Effect of rat andβ-human interferons on hyperacute experimental allergic encephalomyelitis in rats. Agents and Actions 16:5, pages 397-403.
Crossref
Crossref
J.H. Noseworthy, T.P. Seland & G.C. Ebers. (2015) Editorial Review: Therapeutic Trials in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 11:3, pages 355-362.
Crossref
Crossref
Barry G.W. Arnason. (1983) Relevance of Experimental Allergic Encephalomyelitis to Multiple Sclerosis. Neurologic Clinics 1:3, pages 765-782.
Crossref
Crossref
Seymour Levine, Richard Sowinski & Sergio L. Abreu. (1983) Suppression of experimental allergic encephalomyelitis by tilorone: cell transfer and interferon studies. Immunopharmacology 6:1, pages 23-30.
Crossref
Crossref